Introducing Swiss TPH - Excellence in Global Health
Over 800 people from more than 70 nations work at Swiss TPH focusing on infectious and non-communicable diseases, environment, society and health as well as health systems and interventions. They all share the mission to improve population health globally.
New Findings on S. mansoni Life Cycle
For over 50 years, Swiss TPH has researched Schistosomiasis, a neglected tropical disease caused by parasitic flatworms which affects 250 million people globally. A new study details the complex S. mansoni life cycle, contributing to antischistosomal drug discovery.
Photo: Yvette Endriss/Swiss TPH
Read more
One Health in Chad
The Support Project for the Health Districts in Chad (PADS - Programme d'Appui aux Districts Sanitaires au Tchad) aims to strengthen the healthcare system. In order to reach people in remote areas such as nomadic populations, PADS applies a 'One Health' approach taking into account both human and animal health.
PADS is a project of the Swiss Agency for Development and Cooperation.
Click here for French version
MBA in International Health Management
Do you want to become a part of a new generation of leaders in global health?
Swiss TPH’s part-time MBA in International Health Management trains future leaders and managers who want to work in multicultural and transdisciplinary settings.
Learn more about the MBA
A Milestone in the Fight Against Sleeping Sickness
Fexinidazole is the first all-oral drug against sleeping sickness. Swiss TPH contributed significantly to the development of fexinidazole together with DNDi, Sanofi and many others. Since its foundation 75 years ago, Swiss TPH has been researching sleeping sickness. For instance, it was the first to succeed in breeding tsetse flies under laboratory conditions.
Photo: Swiss TPH 1946
More on fexinidazoleNews
All News
13.02.2019
Besuch des Regierungsrats Basel-Landschaft am Swiss TPH
Am 12. Februar 2019 besuchte der Gesamtregierungsrat Basel-Landschaft das Schweizerische Tropen- und Public Health-Institut (Swiss TPH) und gewann so einen Einblick in die... More...
07.02.2019
Pfizer-Preis geht an zwei Swiss TPH Forscher
Kristina Keitel-Hasler und Niklaus Labhardt, beide Forscher in der Clinical Research Unit am Swiss TPH, erhalten den Pfizer Forschungspreis 2019. Der Forschungspreis der Stiftung... More...
31.01.2019
Scientifically Proven: Air Pollution Harms Health
The debate on air quality standards for ambient air pollutants such as nitrogen oxide, particulate matter and ozone has revived in Germany last week. The International Society for... More...
18.12.2018
Buruli Ulcer: Promising New Drug Candidate Against a Forgotten Disease
Buruli ulcer is a neglected tropical disease (NTD) resulting in debilitating skin lesions, disabilities and stigmatisation. The current antibiotic treatment is long and has severe... More...